Pricing Log in Create free account

Cyteir Therapeutics, Inc. (CYTT) vs Tonix Pharmaceuticals Holding Corp. (TNXP)

Cyteir Therapeutics, Inc. and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. Cyteir Therapeutics, Inc. and Tonix Pharmaceuticals Holding Corp. are of similar size ($110.1M and $108.7M). Cyteir Therapeutics, Inc. has the higher net margin (0.00% vs −548.6%) and the higher return on invested capital (0.00% vs −224.5%). Across the 14 metrics below, Cyteir Therapeutics, Inc. leads on 9 and Tonix Pharmaceuticals Holding Corp. on 5.

Valuation

Metric CYTT TNXP Biotechnology median
P/E n/m n/m 8.50
P/S n/m 3.45 9.71
P/B 0.87 0.45 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.55 0.42 0.64
EV/Sales n/m (2.35) 9.21
Earnings yield (31.23%) (219.31%) (33.15%)
Free cash flow yield (23.50%) (157.36%) (25.50%)

Profitability

Metric CYTT TNXP Biotechnology median
Gross margin 0.00% 83.83% 65.16%
Operating margin 0.00% (568.43%) 0.00%
Net margin 0.00% (548.64%) 0.00%
Free cash flow margin 0.00% (543.29%) 0.00%
Return on equity (23.80%) (81.82%) (56.36%)
Return on assets (22.70%) (72.34%) (48.04%)
Return on invested capital 0.00% (224.52%) 0.00%

Growth

Metric CYTT TNXP Biotechnology median
Revenue growth (TTM) — 196.02% 6.02%
EPS growth (last fiscal year) 39.35% 91.75% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CYTT TNXP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 21.89 6.61 4.72
Net debt to EBITDA 3.10 1.68 0.96

Dividend

Metric CYTT TNXP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYTT TNXP Biotechnology median
Market cap 108.72m 110.11m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack